Tech Council of Maryland summit to advance vaccines and treatments
Companies based in Maryland have remarkable opportunities to develop solutions for Ebola, cancer, HIV, malaria, influenza, tuberculosis (TB) and similar infectious diseases. Attendees at the summit will include business leaders, industry researchers and officials from state and federal civilian defense agencies.
“Life sciences companies as well as the educational and government institutions located in Maryland are leading the way in developing life-changing products addressing major health concerns around the world, and more are in the pipeline,” summit chairman Stephen Hoffman said. “Nine of the 50 most influential people in the world’s vaccine industry are based in Maryland, according to a ranking by Vaccine Nation. From cancer immunotherapy and therapeutic vaccines to vaccines for pandemic influenza, Ebola, HIV, TB and malaria, Maryland’s leaders are driving innovation and will be presenting us with their latest updates on progress at this incredibly exciting summit.”
The event takes place at the Bethesda North Marriott Hotel & Conference Center.
“With more than 45 companies conducting 160 clinical trials, and many more novel biotherapeutics in development here in Maryland, as well as the foremost public health institutions, the state has established itself as the epicenter in vaccine and immunotherapeutic innovation,” Tech Council of Maryland CEO Phil Schiff said. “Our summit is a way to bring together leaders in all facets of the vaccine and cancer immunotherapeutic market to discuss new opportunities, as well as ways to collaborate in order to advance health care around the world.”